{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:07:37Z","timestamp":1778832457155,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K06919"],"award-info":[{"award-number":["21K06919"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.path.2023.11.008","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T17:37:44Z","timestamp":1702661864000},"page":"243-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sarcoma of the Lung and Mediastinum"],"prefix":"10.1016","volume":"17","author":[{"given":"Ken-ichi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2023.11.008_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1440-1827.2000.01001.x","article-title":"Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: a systematic study of 100 cases","volume":"50","author":"Iwata","year":"2000","journal-title":"Pathol Int"},{"key":"10.1016\/j.path.2023.11.008_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/his.14783","article-title":"Hypothesis: HEG1 and claudin-4 staining will allow a diagnosis of epithelioid and biphasic mesothelioma versus non-small-cell lung carcinoma with only two stains in most cases","volume":"82","author":"Churg","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.11.008_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/pin.13140","article-title":"Membranous HEG1 expression is a useful marker in the differential diagnosis of epithelioid and biphasic malignant mesothelioma versus carcinomas","volume":"71","author":"Hiroshima","year":"2021","journal-title":"Pathol Int"},{"key":"10.1016\/j.path.2023.11.008_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.pas.0000147401.95391.9a","article-title":"Primary intrathoracic synovial sarcoma: A clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group","volume":"29","author":"B\u00e9gueret","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/modpathol.3800795","article-title":"Primary pulmonary and mediastinal synovial sarcoma: A clinicopathologic study of 60 cases and comparison with five prior series","volume":"20","author":"Hartel","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-016-0513-3","article-title":"Primary pleuropulmonary and mediastinal synovial sarcoma: A clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China","volume":"11","author":"Lan","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1309\/AJCP0B3YJBXWXJII","article-title":"Value of claudin-4 immunostaining in the diagnosis of mesothelioma","volume":"139","author":"Ordonez","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.humpath.2015.09.010","article-title":"The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study","volume":"47","author":"Ito","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/PAS.0000000000001447","article-title":"A\u00a0Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma","volume":"44","author":"Baranov","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41379-021-00910-x","article-title":"Identification of novel SSX1 fusions in synovial sarcoma","volume":"35","author":"Yoshida","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib11","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/PAS.0b013e3182562bc1","article-title":"Liposarcomas of the mediastinum and thorax: A clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features","volume":"36","author":"Boland","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/PAS.0b013e3181e5dc49","article-title":"Dedifferentiated liposarcoma with \"homologous\" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria","volume":"34","author":"Mari\u00f1o-Enr\u00edquez","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/PAS.0b013e3181963c9c","article-title":"Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age","volume":"33","author":"Alaggio","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib15","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41379-021-00862-2","article-title":"Myxoid pleomorphic liposarcoma\u2014a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcoma","volume":"34","author":"Creytens","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/his.12913","article-title":"Comprehensive genetic analysis of a paediatric pleomorphic myxoid liposarcoma reveals near-haploidization and loss of the RB1 gene","volume":"69","author":"Hofvander","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.11.008_bib17","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41379-022-01107-6","article-title":"Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study","volume":"35","author":"Dermawan","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000770","article-title":"Atypical spindle cell lipomatous tumor: clinicopathologic characterization of 232 cases demonstrating a morphologic spectrum","volume":"41","author":"Marino-Enriquez","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib19","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1097\/01.pas.0000170343.09562.39","article-title":"MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data","volume":"29","author":"Binh","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/PAS.0000000000001564","article-title":"DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma","volume":"45","author":"Scapa","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib21","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/s41379-021-00874-y","article-title":"Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature","volume":"34","author":"Koelsche","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/PAS.0000000000000184","article-title":"Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas","volume":"38","author":"Neuville","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00428-022-03293-9","article-title":"Myxoid type and non-myxoid type of intimal sarcoma in large vessels and heart: review of histological and genetic profiles of 20 cases","volume":"480","author":"Yamada","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2023.11.008_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s004280000313","article-title":"Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery","volume":"438","author":"Bode-Lesniewska","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2023.11.008_bib25","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1158\/0008-5472.CAN-10-1543","article-title":"Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma","volume":"70","author":"Dewaele","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.path.2023.11.008_bib26","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1158\/2159-8290.CD-23-0419","article-title":"Clinical activity and exploratory resistance mechanism of milademetan, an MDM2 inhibitor, in intimal sarcoma with MDM2 amplification: an open-label phase 1b\/2 study","volume":"3","author":"Koyama","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.path.2023.11.008_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Mari\u00f1o-Enr\u00edquez","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/his.12910","article-title":"ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours","volume":"69","author":"Yamamoto","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.11.008_bib29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2014.165","article-title":"Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors","volume":"28","author":"Hornick","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.4836","article-title":"ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma","volume":"241","author":"Lee","year":"2017","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable Kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1016\/j.path.2023.11.008_bib33","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jtho.2018.12.003","article-title":"Expanding the molecular characterization of thoracic inflammatory myofibroblastic tumors beyond ALK gene rearrangements","volume":"14","author":"Chang","year":"2019","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.path.2023.11.008_bib34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.humpath.2005.05.011","article-title":"IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung","volume":"36","author":"Zen","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib35","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/resp.12016","article-title":"Immunoglobulin G4-related lung disease: clinicoradiological and pathological features","volume":"18","author":"Matsui","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.path.2023.11.008_bib36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/PAS.0000000000001804","article-title":"Pulmonary \"inflammatory leiomyosarcomas\" are indolent tumors with diploid genomes and no convincing rhabdomyoblastic differentiation","volume":"46","author":"Kao","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib37","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/PAS.0000000000001719","article-title":"Recurrent YAP1-TFE3 gene fusions in clear cell stromal tumor of the lung","volume":"45","author":"Agaimy","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib38","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/0046-8177(95)90092-6","article-title":"Inflammatory sarcomatoid carcinoma of the lung: report of three cases and clinicopathologic comparison with inflammatory pseudotumors in adult patients","volume":"26","author":"Wick","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/his.12952","article-title":"'Inflammatory myofibroblastic tumour'-like dedifferentiation of anaplastic lymphoma kinase-rearranged lung adenocarcinoma","volume":"69","author":"Mason","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.11.008_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/1097-0142(19830201)51:3<452::AID-CNCR2820510317>3.0.CO;2-M","article-title":"lntravascular, bronchiolar, and alveolar tumor of the lung (IVBAT) an analysis of twenty cases of a peculiar sclerosing endothelial tumor","volume":"51","author":"Dail","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.path.2023.11.008_bib41","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/PAS.0000000000001660","article-title":"Clinicopathologic characterization of epithelioid hemangioendothelioma in a series of 62 cases: a proposal of risk stratification and identification of a synaptophysin-positive aggressive subset","volume":"45","author":"Shibayama","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/his.12713","article-title":"CAMTA1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma","volume":"67","author":"Shiba","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.11.008_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAS.0000000000000511","article-title":"Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics","volume":"40","author":"Doyle","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.path.2023.11.008_bib45","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/s41379-021-00879-7","article-title":"YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases","volume":"34","author":"Dermawan","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib46","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A\u00a0novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.path.2023.11.008_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002409","article-title":"Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma","volume":"3","author":"Tanas","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.path.2023.11.008_bib48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/gcc.22839","article-title":"Variant WWTR1 gene fusions in epithelioid hemangioendothelioma-A genetic subset associated with cardiac involvement","volume":"59","author":"Suurmeijer","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.path.2023.11.008_bib49","doi-asserted-by":"crossref","first-page":"45768","DOI":"10.1038\/srep45768","article-title":"HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma","volume":"7","author":"Tsuji","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.path.2023.11.008_bib50","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1097\/PAS.0b013e318227e4d2","article-title":"Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity","volume":"35","author":"Thway","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib51","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/his.12354","article-title":"At the intersection of primary pulmonary myxoid sarcoma and pulmonary angiomatoid fibrous histiocytoma: Observations from three new cases","volume":"65","author":"Smith","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.11.008_bib52","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/PAS.0000000000001548","article-title":"Primary pulmonary myxoid sarcoma and myxoid angiomatoid fibrous histiocytoma: A unifying continuum with shared and distinct features","volume":"44","author":"Gui","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib53","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/PAS.0b013e31824b1ee0","article-title":"Endobronchial pulmonary angiomatoid fibrous histiocytoma: two cases with EWSR1-CREB1 and EWSR1-ATF1 fusions","volume":"36","author":"Thway","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib54","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-014-1645-z","article-title":"Primary pulmonary myxoid sarcomas with EWSR1-CREB1 translocation might originate from primitive peribronchial mesenchymal cells undergoing (myo)fibroblastic differentiation","volume":"465","author":"Jeon","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.path.2023.11.008_bib55","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/10668969221095457","article-title":"Primary pulmonary myxoid sarcoma with EWSR1::ATF1 fusion: a case report","volume":"31","author":"Nishimura","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/PAS.0000000000000560","article-title":"Thoracic myoepithelial tumors: a pathologic and molecular study of 8 cases with review of the literature","volume":"40","author":"Leduc","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib57","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/PAS.0b013e318220e085","article-title":"Pulmonary tumor with notochordal differentiation: report of 2 cases suggestive of benign notochordal cell tumor of extraosseous origin","volume":"35","author":"Kikuchi","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib58","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/j.cllc.2021.02.012","article-title":"Where is the\u00a0primary site of the extra-axial chordoma masquerading as lung cancer?","volume":"22","author":"Kikuchi","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.path.2023.11.008_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/his.13072","article-title":"Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours","volume":"70","author":"Asano","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.11.008_bib60","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/PAS.0000000000000564","article-title":"Loss of H3K27me3 expression is a highly sensitive marker for sporadic and radiation-induced MPNST","volume":"40","author":"Prieto-Granada","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib61","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41379-018-0140-5","article-title":"H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features","volume":"32","author":"Makise","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib62","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/pin.13293","article-title":"Ewing and Ewing-like sarcomas: A morphological guide through genetically-defined entities","volume":"73","author":"Yoshida","year":"2023","journal-title":"Pathol Int"},{"key":"10.1016\/j.path.2023.11.008_bib63","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/PAS.0b013e318289c765","article-title":"A\u00a0study of gata3 and phox2b expression in tumors of the autonomic nervous system","volume":"37","author":"Nonaka","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib64","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/his.13288","article-title":"PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours","volume":"71","author":"Hung","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2023.11.008_bib65","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","article-title":"Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody","volume":"33","author":"Haack","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/modpathol.2017.11","article-title":"Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities","volume":"30","author":"Yoshida","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2023.11.008_bib67","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jtho.2019.10.023","article-title":"SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas","volume":"15","author":"Rekhtman","year":"2020","journal-title":"J\u00a0Thorac Oncol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123001009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123001009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:11:58Z","timestamp":1778829118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918123001009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1875918123001009"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2023.11.008","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoma of the Lung and Mediastinum","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2023.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}